HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
96.72%
Total 13F principal
$403,178,000
Principal change
-$7,862,000
Total reported market value
$390,684,886
Number of holders
27
Value change
-$5,972,301
Number of buys
10
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q3 2016

As of 30 Sep 2016, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 27 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $403,178,000 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT CO, OAKTREE CAPITAL MANAGEMENT LP, KINGDON CAPITAL MANAGEMENT, L.L.C., Lion Point Capital, LP, LINDEN ADVISORS LP, FMR LLC, CNH PARTNERS LLC, ADVENT CAPITAL MANAGEMENT /DE/, CALAMOS ADVISORS LLC, and Nicholas Investment Partners, LP. This page lists 27 institutional bondholders reporting positions for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.